INCR — InterCure Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall Cap

Annual cashflow statement for InterCure, fiscal year end - December 31st, ILS millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-36	7.29	43.7	-63.5	-72.8
Depreciation
Non-Cash Items	44.8	28.9	6.81	95.5	12.6
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-4.21	-13.4	-11	-98.8	-22.1
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	7.8	30.1	51.3	-53.6	-66.9
Capital Expenditures	-20.8	-14	-19.7	-2.62	-4.83
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1.92	-51.2	-123	7.39	22.5
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities	-22.8	-65.2	-142	4.77	17.7
Financing Cash Flow Items	—	-5.12	-17.3	-20.9	18.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	25.3	198	120	-82.9	26.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	10.6	158	36.4	-131	-22.8